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West Nile Virus in
Horses, Guatemala
To the Editor: West Nile virus
(WNV,  Flaviviridae: Flavivirus) is
emerging as a public health and vet-
erinary concern. Since its introduction
into North America in 1999, it has
spread rapidly, reaching the
Caribbean Basin in 2001, Mexico in
2002, El Salvador in 2003, and
Colombia in 2004 (1). However,
reports of equine illness and deaths in
Latin America are inconclusive. With
the exception of viral isolates from a
dead bird, a human, and a mosquito
pool in Mexico (2,3), all reports of
WNV presence in Latin America have
relied on serologic evidence. WNV is
a member of the Japanese encephalitis
serocomplex, which in the Western
Hemisphere includes St. Louis
encephalitis virus (SLEV) (4).
Serologic investigations for WNV in
Latin America must use highly specif-
ic assays to differentiate WNV infec-
tion from potentially cross-reactive
viruses such as SLEV or possibly
additional unknown viruses. In partic-
ular, SLEV is of concern since it was
previously isolated from Guatemalan
mosquitoes (5).
Alerted by the findings of WNV
transmission in the region (1), we col-
lected serum samples from horses
from 19 departments of Guatemala
from September 2003 to March 2004,
to initially estimate the extent of
WNV spread and its potential public
health risk. Because no animals
exhibited signs of neurologic illness
at the time of the survey, only healthy
horses were sampled. Before 2005,
equine WNV vaccines were prohibit-
ed and unavailable in Guatemala
(Unidad de Normas y Regulaciones,
Ministerio de Agricultura Ganadería y
Alimentación, Guatemala, pers.
comm.); as such, cross-reactivity due
to prior vaccination is highly unlikely.
Samples were initially tested for
WNV-reactive antibodies by using an
epitope-blocking enzyme-linked
immunosorbent assay (blocking
ELISA) (6). The ability of the test sera
to block the binding of the monoclon-
al antibodies to WNV antigen was
compared to the blocking ability of
control horse serum without antibody
to WNV. Data were expressed as rela-
tive percentages and inhibition values
>30% were considered to indicate the
presence of viral antibodies.
A subset of positive samples was
further confirmed by plaque-reduc-
tion neutralization test (7). Of 352
samples, 149 (42.3%) tested positive
with the 3.1112G WNV-specific mon-
oclonal antibody. Of 70 blocking
ELISA–positive samples, the neutral-
ization tests indicated the infecting
agent was WNV, SLEV, and undiffer-
entiated flavivirus in 9, 33, and 21
samples, respectively. Titers were
expressed as the reciprocal of serum
dilutions yielding >90% reduction in
the number of plaques in a plaque-
reduction neutralization test
(PRNT90). PRNT90 titers of horses
seropositive for WNV ranged from 80
to 320. PRNT90 titers of horses
seropositive for SLEVranged from 40
to 2,560. For the differential diagnosis
of samples with neutralizing antibody
titers against both WNV and SLEV in
this test, a >4-fold titer difference was
used to identify the etiologic agent.
The undifferentiated flavivirus-reac-
tive specimens had <4-fold difference
in cross-neutralization titers. Likely
possibilities for the inability to distin-
guish the infecting virus include pre-
vious infection with these or other fla-
viviruses (previously described or
unknown) resulting in elevated cross-
reactive titers. The remaining 10% of
specimens that tested negative by
PRNT probably represent nonneutral-
izing antibodies in the serum or false
positivity in the blocking ELISA.
Our serologic results provide indi-
rect evidence of past transmission of
WNV, SLEV, and possibly other fla-
viviruses to horses in Guatemala.
Although no confirmed cases of
WNV-attributed disease have been
reported in Central America to date,
flavivirus transmission appears to be
widely distributed in Guatemala
(Figure). Efforts are under way to
confirm WNV transmission by viral
isolation and to evaluate the impact of
WNV on human, horse, and wildlife
populations. More information is
needed to establish the public health
threat of WNV and other zoonotic fla-
viviruses in the region.
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To the Editor: Lyme disease is a
multisystem disorder associated with
skin, myocardial, musculoskeletal,
and central and peripheral nervous
system manifestations caused by
infection with Borrelia burgdorferi
sensu lato spirochetes (1). In the
United States, the illness is caused by
transmission of B. burgdorferi sensu
stricto from the bite of infected Ixodes
scapularis (deer) ticks found primari-
ly in the northeastern and upper mid-
western United States (2). B. burgdor-
feri–infected ticks have also been
recovered in portions of northern
Illinois but have not yet been reported
in the Chicago region (3). In fact, a
previous survey (4) of forested areas
in the heavily populated regions
immediately adjacent to Chicago con-
firmed a low risk of contracting Lyme
disease. Researchers failed to recover
deer ticks from 7 sampling sites and
recovered only a single Borrelia iso-
late from well-described B. burgdor-
feri sensu stricto rodent reservoirs
(mice, voles, chipmunks) captured
from 5 sampling sites. A subsequent
genetic analysis confirmed the isolate
was B. bissettii (5), a genomic group
that is likely nonpathogenic to
humans in the United States.
However, the area of the Midwest
where Lyme disease is endemic has
continued to expand from its origin in
northeastern Minnesota and north-
western Wisconsin (2,6). The Chicago
metropolitan region has numerous
parks and natural areas that are bio-
logically similar to the known mid-
western focus (7), and these areas
support a large population of white-
tailed deer. Moreover, we have seen
anecdotal reports of persons with clin-
ical signs and symptoms of Lyme dis-
ease and epidemiologic evidence that
suggests local acquisition. Two ticks
submitted by a resident who had hiked
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Figure. Geographic distribution in Guatemala of horses showing previous infections with
West Nile virus (WNV), Saint Louis encephalitis virus (SLEV), or undifferentiated flavivirus
as confirmed by plaque reduction neutralization test. Each location may have multiple
positive horses.